A drug to treat advanced prostate cancer should be given to patients on the NHS, a health watchdog has said.
Abirateron, marketed as Zytiga, can extend the lives of late-stage cancer sufferers by more than three months.
The National Institute for Health and Clinical Excellence (Nice) revised its recommendations after fresh information from manufacturer Janssen, and the new draft guidance was welcomed by experts.
More top news
Ofcom proposed that BT's Openreach network become a "distinct company" within the BT Group - but stopped short of calling for a sell-off.
Most areas should start off dry, but showery outbreaks of rain will move eastwards across the UK throughout the day.
The First Lady's masterly performance, combined with Bernie Sanders' impressive speech, saved a convention that was fraying at the edges.